Zoonotic Disease Treatment Market Size, Share and Forecast 2024-2031

Zoonotic Disease Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

<h2>Global Zoonotic Disease Treatment Market is segmented By Disease Type (Rabies, Hepatitis, Lyme disease, Plague, Malaria, Others) By Causative Agent (Bacteria, Virus, Nematodes, Rodents, Ticks, Others)&nbsp;By Drug Type (Antifungal medication, Antibacterial medication, Antibiotics, Others) By End Users (Hospitals and Clinics, Ambulatory Surgical Centers, Others)&nbsp;and By Region (North America, Europe, South America, Asia Pacific, Middle East, and Africa) &ndash; Share, Size, Outlook, and Opportunity Analysis, 2024-2031</h2>

<h3>Market Overview</h3>

<blockquote>
Global Zoonotic Disease Treatment market reached US$ YY&nbsp;million in 2023 and is expected to reach US$ YY&nbsp;million by 2031, growing at a CAGR of YY% during the forecast period 2024-2031.
</blockquote>

Zoonotic diseases such as rabies, lyme disease, bird flu, hepatitis, and plague are a few which are prevalent in certain parts of the world. These Zoonotic infections are caused by bacteria, viruses, parasites, fungi, nematodes, and rodents and spread through contaminated food and water, direct and indirect contact with animals. According to WHO, there are more than 200 known types of zoonotic infections.&nbsp;&nbsp;

<h3>Market Scope</h3>

<table cellspacing="0" style="border-collapse:collapse">
	<tbody>
		<tr>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-left:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Metrics
			</td>
			<td style="background-color:#4472c4; border-bottom:1px solid #4472c4; border-right:1px solid #4472c4; border-top:1px solid #4472c4; vertical-align:top; width:312px">
			Details
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			CAGR
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #4472c4; vertical-align:middle; width:312px">
			YY%
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Market Size Available for Years
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2022-2031
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Estimation Forecast Period
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			2024-2031
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Revenue Units
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Value (US$ Mn)&nbsp;
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Segments Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Disease Type, Causative Agent, Drug Type, End Users
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Regions Covered
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America, Europe, Asia-Pacific, South America, and Middle East &amp; Africa
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Largest Region
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			North America
			</td>
		</tr>
		<tr>
			<td style="border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Fastest Growing Region
			</td>
			<td style="border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Asia-Pacific
			</td>
		</tr>
		<tr>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-left:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Report Insights Covered
			</td>
			<td style="background-color:#d9e2f3; border-bottom:1px solid #8eaadb; border-right:1px solid #8eaadb; border-top:1px solid #8eaadb; vertical-align:middle; width:312px">
			Competitive Landscape Analysis, Company Profile Analysis, Market Size, Share, Growth, Demand, Recent Developments, Mergers and Acquisitions, New Product Launches, Growth Strategies, Revenue Analysis, Porter&rsquo;s Analysis, Pricing Analysis, Regulatory Analysis, Supply-Chain Analysis and Other key Insights.
			</td>
		</tr>
	</tbody>
</table>

&nbsp;

For more details on this report &ndash; <a href="https://www.datamintelligence.com/download-sample/zoonotic-disease-treatment-market" target="_blank">Request for Sample</a>

<h3>&nbsp;</h3>

<h3>Market Dynamics: Drivers &amp; Restraints</h3>

Increasing awareness about zoonotic diseases&nbsp;

Zoonotic diseases are transmitted from animals to humans which is increasing the global health burden. According to the National Center for Biotechnology Information, 2023, Zoonotic diseases are responsible for 2.5 billion human cases globally and approximately 2.7 million deaths annually. They are responsible for more than 60% of all recognized human diseases and 75% of emerging infectious diseases.

Due to the zoonotic disease prevalence, government organizations are launching programs and campaigns to raise awareness among people. For instance, in July 2023, WHO launched the &ldquo;One Life, one Liver&rdquo; campaign on World Hepatitis Day.

In July 2023, SMC (Srinagar Municipal Corporation) launched Animal Birth Control and anti-rabies vaccination program. The initiative aims to curb the overpopulation of stray dogs while eliminating the threat of rabies transmission within the community

In January 2024, according to the Food and Agriculture Organization launched a program &quot;Enhancing Animal Health &amp; One Health Capacities to Mitigate Zoonotic Diseases and Antimicrobial Resistance Risks &amp; Threats&quot; in collaboration with the United States Agency for International Development (USAID) Malawi, The Malawi Government.

Limited access to healthcare

Healthcare access such as services like prevention, diagnosis, treatment, and management of zoonotic diseases in low-income countries is very limited. It creates a barrier to obtaining proper medical care for deadly diseases like Lyme disease, hepatitis, etc. According to the Rural Health Information Hub, as of September 2022, 65.6% of Primary Care Health Professional Shortage Areas (HPSAs) were located in rural areas. Furthermore, poor health literacy, workforce shortages, social stigma, and privacy issues limit access to healthcare services in rural areas.&nbsp;&nbsp;

<h3>Segment Analysis</h3>

The global zoonotic disease treatment market is segmented based on disease type, causative agent, drug type, end user and region.

Vaccines Drug Type is Expected to Dominate Market

Increasing strategies by key companies and government organizations are expected to drive the market. Due to an increase in the vaccination drives conducted in low-income countries by government organizations, there is growing awareness of vaccines and other drugs.

For instance, in October 2023, UNICEF signed a deal with Serum Life Sciences for 2024 &ndash; 2028 for a secure supply of the world&rsquo;s second malaria vaccine, R21/Matrix-M. The deal is a major milestone towards meeting the high demand for doses of new vaccines against malaria

Furthermore, in January 2024, Indian Immunologicals Ltd (IIL) launched India&rsquo;s &lsquo;first&rsquo; indigenously developed Hepatitis A vaccine, Havisure. Also, in March 2023, Cadila Pharma&#39;s novel three-dose rabies vaccine ThRabis under trial for use in children.

<h3>Geographical Analysis</h3>

North America is Expected to Dominate the Global Market

North America is expected to hold the largest share in the market owing to the rapid urbanization, and expansion of healthcare facilities for the development of new drugs and vaccines. Technological advancements also play a huge role in the zoonotic disease treatment market.&nbsp;

Major key players such as Merck &amp; Co., Inc., Johnson &amp; Johnson, etc are continuously working on the development of new drugs and vaccines for diseases like rabies, hepatitis, etc to eradicate the diseases from the US. Due to the presence of cutting-edge infrastructure, rise in government policies to decrease the burden of zoonotic diseases, and increasing investments in R&amp;D in North America, the market is expected to hold the largest share.&nbsp;&nbsp;

<h3>Key Developments</h3>

<ul>
	<li>In November 2023, Indian Immunologicals Ltd (IIL) launched the measles and rubella vaccine for children.</li>
	<li>In March 2023, GSK plc and SCYNEXIS, Inc. agreed to commercialize Brexafemme (ibrexafungerp tablets), a US FDA-approved, first-in-class antifungal for the treatment of vulvovaginal candidiasis (VVC) and reduction in the incidence of recurrent VVC (RVVC).</li>
</ul>

<h3>Competitive Landscape</h3>

The major global players in the zoonotic disease treatment market include Merck &amp; Co., Inc, GlaxoSmithKline plc, Pfizer, Inc., Sanofi S.A., Novartis AG, Johnson &amp; Johnson, AstraZeneca Plc, Zydus Lifesciences Limited, F Hoffmann-La Roche Inc., Eli Lilly and Company among others.

<h3>Why Purchase the Report?</h3>

<ul>
	<li>To visualize the global zoonotic disease treatment market segmentation based on disease type, causative agent, drug type, end user, and region as well as understand key commercial assets and players.</li>
	<li>Identify commercial opportunities by analyzing trends and co-development.&nbsp;</li>
	<li>Excel data sheet with numerous data points of zoonotic disease treatment market-level with all segments.</li>
	<li>PDF report consists of a comprehensive analysis after exhaustive qualitative interviews and an in-depth study.</li>
	<li>Product mapping available as excel consisting of key products of all the major players.</li>
</ul>

The global zoonotic disease treatment market report would provide approximately 65 tables,751 figures and 186 pages.

<h3>Target Audience 2024</h3>

<ul>
	<li>Manufacturers/ Buyers</li>
	<li>Industry Investors/Investment Bankers</li>
	<li>Research Professionals</li>
	<li>Emerging Companies</li>
</ul>

<ol>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Methodology and Scope</h3>

	<ol>
		<li>Research Methodology</li>
		<li>Research Objective and Scope of the Report</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Definition and Overview</h3>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Executive Summary</h3>

	<ol>
		<li>Snippet by Disease Type</li>
		<li>Snippet by Causative Agent</li>
		<li>Snippet by Drug Type</li>
		<li>Snippet by End User</li>
		<li>Snippet by Region</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Dynamics</h3>

	<ol>
		<li>Impacting Factors
		<ol>
			<li>Drivers
			<ol>
				<li>Increasing awareness about zoonotic diseases&nbsp;</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Restraints
			<ol>
				<li>Limited access to healthcare</li>
				<li>XX</li>
			</ol>
			</li>
			<li>Opportunity</li>
			<li>Impact Analysis</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Industry Analysis&nbsp;</h3>

	<ol>
		<li>Porter&#39;s Five Force Analysis&nbsp;</li>
		<li>Supply Chain Analysis</li>
		<li>Pricing Analysis</li>
		<li>Regulatory Analysis</li>
		<li>Reimbursement Analysis</li>
		<li>Patent Analysis</li>
		<li>Pipeline Analysis</li>
		<li>Epidemiology&nbsp;</li>
		<li>SWOT Analysis</li>
		<li>DMI Opinion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">COVID-19 Analysis</h3>

	<ol>
		<li>Analysis of COVID-19
		<ol>
			<li>Scenario Before COVID</li>
			<li>Scenario During COVID</li>
			<li>Scenario Post COVID</li>
		</ol>
		</li>
		<li>Pricing Dynamics Amid COVID-19</li>
		<li>Demand-Supply Spectrum</li>
		<li>Government Initiatives Related to the Market During Pandemic</li>
		<li>Manufacturers Strategic Initiatives</li>
		<li>Conclusion</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Disease Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Attractiveness Index, By Disease Type</li>
		</ol>
		</li>
		<li>Rabies*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Hepatitis</li>
		<li>Lyme disease</li>
		<li>Plague</li>
		<li>Malaria</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Causative Agent</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Causative Agent</li>
			<li>Market Attractiveness Index, By Causative Agent</li>
		</ol>
		</li>
		<li>Bacteria*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Virus</li>
		<li>Nematodes</li>
		<li>Rodents</li>
		<li>Ticks</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Drug Type</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Attractiveness Index, By Drug Type</li>
		</ol>
		</li>
		<li>Antifungal medication*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Antibacterial medication</li>
		<li>Antibiotics</li>
		<li>Vaccines</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By End Users</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Attractiveness Index, By End User</li>
		</ol>
		</li>
		<li>Hospitals and Clinics*
		<ol>
			<li>Introduction</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%)</li>
		</ol>
		</li>
		<li>Ambulatory Surgical Centers</li>
		<li>Others</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">By Region</h3>

	<ol>
		<li>Introduction
		<ol>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Region</li>
			<li>Market Attractiveness Index, By Region</li>
		</ol>
		</li>
		<li>North America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Causative Agent</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>U.S.</li>
				<li>Canada</li>
				<li>Mexico</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Europe
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Causative Agent</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Germany</li>
				<li>UK</li>
				<li>France</li>
				<li>Italy</li>
				<li>Spain</li>
				<li>Rest of Europe</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>South America
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Causative Agent</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>Brazil</li>
				<li>Argentina</li>
				<li>Rest of South America</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Asia-Pacific
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Causative Agent</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
			<ol>
				<li>China</li>
				<li>India</li>
				<li>Japan</li>
				<li>Australia</li>
				<li>Rest of Asia-Pacific</li>
			</ol>
			</li>
		</ol>
		</li>
		<li>Middle East and Africa
		<ol>
			<li>Introduction</li>
			<li>Key Region-Specific Dynamics</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Disease Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Causative Agent</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By Drug Type</li>
			<li>Market Size Analysis and Y-o-Y Growth Analysis (%), By End User</li>
		</ol>
		</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Competitive Landscape</h3>

	<ol>
		<li>Competitive Scenario</li>
		<li>Market Positioning/Share Analysis</li>
		<li>Mergers and Acquisitions Analysis</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Company Profiles</h3>

	<ol>
		<li>Merck &amp; Co., Inc*
		<ol>
			<li>Company Overview</li>
			<li>Product Portfolio and Description</li>
			<li>Financial Overview</li>
			<li>Key Developments</li>
		</ol>
		</li>
		<li>GlaxoSmithKline plc</li>
		<li>Pfizer, Inc.</li>
		<li>Sanofi S.A.</li>
		<li>Novartis AG</li>
		<li>Johnson &amp; Johnson</li>
		<li>AstraZeneca Plc</li>
		<li>Zydus Lifesciences Limited</li>
		<li>F Hoffmann-La Roche Inc.</li>
		<li>Eli Lilly and Company&nbsp;(LIST NOT EXHAUSTIVE)&nbsp;</li>
	</ol>
	</li>
	<li>
	<h3 style="color:#1f3863; font-style:normal">Appendix</h3>

	<ol>
		<li>About Us and Services</li>
		<li>Contact Us</li>
	</ol>
	</li>
</ol>

List of Tables

Table 1 Global Zoonotic Disease Treatment Market Value, By Disease Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 2 Global Zoonotic Disease Treatment Market Value, By Causative Agent, 2023, 2027 &amp; 2031 (US$ Million)

Table 3 Global Zoonotic Disease Treatment Market Value, By Drug Type, 2023, 2027 &amp; 2031 (US$ Million)

Table 4 Global Zoonotic Disease Treatment Market Value, By End-User, 2023, 2027 &amp; 2031 (US$ Million)

Table 5 Global Zoonotic Disease Treatment Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 6 Global Zoonotic Disease Treatment Market Value, By Disease Type, 2022-2031 (US$ Million)

Table 7 Global Zoonotic Disease Treatment Market Value, By Causative Agent, 2022-2031 (US$ Million)

Table 8 Global Zoonotic Disease Treatment Market Value, By Drug Type, 2022-2031 (US$ Million)

Table 9 Global Zoonotic Disease Treatment Market Value, By End-User, 2022-2031 (US$ Million)

Table 10 Global Zoonotic Disease Treatment Market Value, By Region, 2023, 2027 &amp; 2031 (US$ Million)

Table 11 Global Zoonotic Disease Treatment Market Value, By Region, 2022-2031 (US$ Million)

Table 12 North America Zoonotic Disease Treatment Market Value, By Disease Type, 2022-2031 (US$ Million)

Table 13 North America Zoonotic Disease Treatment Market Value, By Causative Agent, 2022-2031 (US$ Million)

Table 14 North America Zoonotic Disease Treatment Market Value, By Drug Type, 2022-2031 (US$ Million)

Table 15 North America Zoonotic Disease Treatment Market Value, By End-User, 2022-2031 (US$ Million)

Table 16 North America Zoonotic Disease Treatment Market Value, By Country, 2022-2031 (US$ Million)

Table 17 South America Zoonotic Disease Treatment Market Value, By Disease Type, 2022-2031 (US$ Million)

Table 18 South America Zoonotic Disease Treatment Market Value, By Causative Agent, 2022-2031 (US$ Million)

Table 19 South America Zoonotic Disease Treatment Market Value, By Drug Type, 2022-2031 (US$ Million)

Table 20 South America Zoonotic Disease Treatment Market Value, By End-User, 2022-2031 (US$ Million)

Table 21 South America Zoonotic Disease Treatment Market Value, By Country, 2022-2031 (US$ Million)

Table 22 Europe Zoonotic Disease Treatment Market Value, By Disease Type, 2022-2031 (US$ Million)

Table 23 Europe Zoonotic Disease Treatment Market Value, By Causative Agent, 2022-2031 (US$ Million)

Table 24 Europe Zoonotic Disease Treatment Market Value, By Drug Type, 2022-2031 (US$ Million)

Table 25 Europe Zoonotic Disease Treatment Market Value, By End-User, 2022-2031 (US$ Million)

Table 26 Europe Zoonotic Disease Treatment Market Value, By Country, 2022-2031 (US$ Million)

Table 27 Asia-Pacific Zoonotic Disease Treatment Market Value, By Disease Type, 2022-2031 (US$ Million)

Table 28 Asia-Pacific Zoonotic Disease Treatment Market Value, By Causative Agent, 2022-2031 (US$ Million)

Table 29 Asia-Pacific Zoonotic Disease Treatment Market Value, By Drug Type, 2022-2031 (US$ Million)

Table 30 Asia-Pacific Zoonotic Disease Treatment Market Value, By End-User, 2022-2031 (US$ Million)

Table 31 Asia-Pacific Zoonotic Disease Treatment Market Value, By Country, 2022-2031 (US$ Million)

Table 32 Middle East &amp; Africa Zoonotic Disease Treatment Market Value, By Disease Type, 2022-2031 (US$ Million)

Table 33 Middle East &amp; Africa Zoonotic Disease Treatment Market Value, By Causative Agent, 2022-2031 (US$ Million)

Table 34 Middle East &amp; Africa Zoonotic Disease Treatment Market Value, By Drug Type, 2022-2031 (US$ Million)

Table 35 Middle East &amp; Africa Zoonotic Disease Treatment Market Value, By End-User, 2022-2031 (US$ Million)

Table 36 Merck &amp; Co., Inc: Overview

Table 37 Merck &amp; Co., Inc: Product Portfolio

Table 38 Merck &amp; Co., Inc: Key Developments

Table 39 GlaxoSmithKline plc: Overview

Table 40 GlaxoSmithKline plc: Product Portfolio

Table 41 GlaxoSmithKline plc: Key Developments

Table 42 Pfizer, Inc.: Overview

Table 43 Pfizer, Inc.: Product Portfolio

Table 44 Pfizer, Inc.: Key Developments

Table 45 Sanofi S.A.: Overview

Table 46 Sanofi S.A.: Product Portfolio

Table 47 Sanofi S.A.: Key Developments

Table 48 Novartis AG: Overview

Table 49 Novartis AG: Product Portfolio

Table 50 Novartis AG: Key Developments

Table 51 Johnson &amp; Johnson: Overview

Table 52 Johnson &amp; Johnson: Product Portfolio

Table 53 Johnson &amp; Johnson: Key Developments

Table 54 AstraZeneca Plc: Overview

Table 55 AstraZeneca Plc: Product Portfolio

Table 56 AstraZeneca Plc: Key Developments

Table 57 Zydus Lifesciences Limited: Overview

Table 58 Zydus Lifesciences Limited: Product Portfolio

Table 59 Zydus Lifesciences Limited: Key Developments

Table 60 F Hoffmann-La Roche Inc.: Overview

Table 61 F Hoffmann-La Roche Inc.: Product Portfolio

Table 62 F Hoffmann-La Roche Inc.: Key Developments

Table 63 Eli Lilly and Company: Overview

Table 64 Eli Lilly and Company: Product Portfolio

Table 65 Eli Lilly and Company: Key Developments

List of Figures

Figure 1 Global Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 2 Global Zoonotic Disease Treatment Market Share, By Disease Type, 2022 &amp; 2031 (%)

Figure 3 Global Zoonotic Disease Treatment Market Share, By Causative Agent, 2022 &amp; 2031 (%)

Figure 4 Global Zoonotic Disease Treatment Market Share, By Drug Type, 2022 &amp; 2031 (%)

Figure 5 Global Zoonotic Disease Treatment Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 6 Global Zoonotic Disease Treatment Market Share, By Region, 2022 &amp; 2031 (%)

Figure 7 Global Zoonotic Disease Treatment Market Y-o-Y Growth, By Disease Type, 2022-2031 (%)

Figure 8 Rabies Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 9 Hepatitis Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 10 Lyme disease Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 11 Plague Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 12 Malaria Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 13 Others Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 14 Global Zoonotic Disease Treatment Market Y-o-Y Growth, By Causative Agent, 2022-2031 (%)

Figure 15 Bacteria Causative Agent in Global Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 16 Virus Causative Agent in Global Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 17 Nematodes Causative Agent in Global Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 18 Rodents Causative Agent in Global Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 19 Ticks Causative Agent in Global Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 20 Others Causative Agent in Global Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 21 Global Zoonotic Disease Treatment Market Y-o-Y Growth, By Drug Type, 2022-2031 (%)

Figure 22 Antifungal medication Drug Type in Global Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 23 Antibacterial medication Drug Type in Global Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 24 Antibiotics Drug Type in Global Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 25 Vaccines Drug Type in Global Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 26 Others Drug Type in Global Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 27 Global Zoonotic Disease Treatment Market Y-o-Y Growth, By End-User, 2022-2031 (%)

Figure 28 Hospitals and Clinics in Global Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 29 Ambulatory Surgical Centers in Global Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 30 Others in Global Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 31 Global Zoonotic Disease Treatment Market Y-o-Y Growth, By Region, 2022-2031 (%)

Figure 32 North America Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 33 Asia-Pacific Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 34 Europe Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 35 South America Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 36 Middle East and Africa Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 37 North America Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 38 North America Zoonotic Disease Treatment Market Share, By Disease Type, 2022 &amp; 2031 (%)

Figure 39 North America Zoonotic Disease Treatment Market Share, By Causative Agent, 2022 &amp; 2031 (%)

Figure 40 North America Zoonotic Disease Treatment Market Share, By Drug Type, 2022 &amp; 2031 (%)

Figure 41 North America Zoonotic Disease Treatment Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 42 North America Zoonotic Disease Treatment Market Share, By Country, 2022 &amp; 2031 (%)

Figure 43 South America Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 44 South America Zoonotic Disease Treatment Market Share, By Disease Type, 2022 &amp; 2031 (%)

Figure 45 South America Zoonotic Disease Treatment Market Share, By Causative Agent, 2022 &amp; 2031 (%)

Figure 46 South America Zoonotic Disease Treatment Market Share, By Drug Type, 2022 &amp; 2031 (%)

Figure 47 South America Zoonotic Disease Treatment Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 48 South America Zoonotic Disease Treatment Market Share, By Country, 2022 &amp; 2031 (%)

Figure 49 Europe Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 50 Europe Zoonotic Disease Treatment Market Share, By Disease Type, 2022 &amp; 2031 (%)

Figure 51 Europe Zoonotic Disease Treatment Market Share, By Causative Agent, 2022 &amp; 2031 (%)

Figure 52 Europe Zoonotic Disease Treatment Market Share, By Drug Type, 2022 &amp; 2031 (%)

Figure 53 Europe Zoonotic Disease Treatment Market Share, By End-User, 2022 &amp; 2031 (%)

Figure 54 Europe Zoonotic Disease Treatment Market Share, By Country, 2022 &amp; 2031 (%)

Figure 55 Asia-Pacific Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 56 Asia-Pacific Zoonotic Disease Treatment Market Share, By Disease Type, 2022 &amp; 2031 (%)

Figure 57 Asia-Pacific Zoonotic Disease Treatment Market Share, By Causative Agent, 2022 &amp; 2031 (%)

Figure 58 Asia-Pacific Zoonotic Disease Treatment Market Share, By Drug Type, 2022 &amp; 2031 (%)

Figure 59 Asia-Pacific Zoonotic Disease Treatment Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 60 Asia-Pacific Zoonotic Disease Treatment Market Share, By Country, 2023 &amp; 2031 (%)

Figure 61 Middle East &amp; Africa Zoonotic Disease Treatment Market Value, 2022-2031 (US$ Million)

Figure 62 Middle East &amp; Africa Zoonotic Disease Treatment Market Share, By Disease Type, 2023 &amp; 2031 (%)

Figure 63 Middle East &amp; Africa Zoonotic Disease Treatment Market Share, By Causative Agent, 2023 &amp; 2031 (%)

Figure 64 Middle East &amp; Africa Zoonotic Disease Treatment Market Share, By Drug Type, 2023 &amp; 2031 (%)

Figure 65 Middle East &amp; Africa Zoonotic Disease Treatment Market Share, By End-User, 2023 &amp; 2031 (%)

Figure 66 Merck &amp; Co., Inc: Financials

Figure 67 GlaxoSmithKline plc: Financials

Figure 68 Pfizer, Inc.: Financials

Figure 69 Sanofi S.A.: Financials

Figure 70 Novartis AG: Financials

Figure 71 Johnson &amp; Johnson: Financials

Figure 72 AstraZeneca Plc: Financials

Figure 73 Zydus Lifesciences Limited: Financials

Figure 74 F Hoffmann-La Roche Inc.: Financials

Figure 75 Eli Lilly and Company: Financials

Zoonotic Disease Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Human Anti-rabies Vaccine Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 January 22

Starting from

Hepatitis B Treatment Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 February 27

Starting from

Anti-malarial Drugs Market Size, Share, Industry, Forecast and outlook (2024-2031)

Published: 2024 March 01

Starting from